0.10Open0.10Pre Close0 Volume7 Open Interest15.00Strike Price0.00Turnover107.32%IV27.00%PremiumNov 15, 2024Expiry Date0.00Intrinsic Value100Multiplier9DDays to Expiry0.10Extrinsic Value100Contract SizeAmericanOptions Type0.1077Delta0.0893Gamma118.90Leverage Ratio-0.0196Theta0.0003Rho12.81Eff Leverage0.0036Vega
KKR Real Estate Finance Trust Stock Discussion
• $Okta (OKTA.US)$ +15.8% (In reaction to earnings)
• $StoneCo (STNE.US)$ +12.9% (In reaction to earnings)
• $Turning Point Therapeutics (TPTX.US)$ +116.8% (Bristol Myers Squibb (BMY) will acquire Turning Point Therapeutics for $76,00 per share; expected to be accretive to Non-GAAP earnings per share beginningin2025)
• $Amylyx Pharmaceuticals (AMLX.US)$ +24.9% (receives PDUFA date extension for AMX0035; scheduled for September ...
No comment yet